- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Cefazolin Recommended for Antibiotic Prophylaxis in Patients with Penicillin Allergy in Obstetrics and Gynecology: Study
USA: A recent clinical opinion published in the American Journal of Obstetrics and Gynecology supports cefazolin use as a primary antibiotic for prophylaxis in obstetric and gynecological patients with a history of penicillin allergy, even among those who have experienced anaphylactic reactions. This recommendation marks a significant step in ensuring effective antimicrobial care while addressing patient safety concerns.
"The sole exceptions are patients with a history of severe, life-threatening delayed hypersensitivity reactions, including Stevens-Johnson Syndrome. It is essential to incorporate more referrals for penicillin allergy testing into routine obstetric care and preoperative evaluations," Karley J. Dutra, Department of Obstetrics and Gynecology, Medical University of South Carolina, Charleston, SC, and colleagues wrote.
Cefazolin is the primary antibiotic used for prophylaxis in obstetrics and gynecology. However, many patients with a penicillin allergy are prescribed alternative antibiotics due to concerns about potential cross-reactivity with cefazolin. These alternatives can lead to negative outcomes, such as increased risk of surgical site infections, the development of antibiotic resistance, higher healthcare costs, and the potential for Clostridium difficile infections. The authors highlight that this situation has significant negative consequences for the patients under our care. They advocate for ongoing education among obstetrician-gynecologists and the delabeling of penicillin allergies to optimize antimicrobial prophylaxis.
According to the study authors, the differences in R1 side chains between penicillin and cefazolin suggest that cefazolin is safe for use in patients with penicillin allergy, including those who have experienced IgE-mediated reactions such as anaphylaxis. They emphasize that cefazolin should be avoided only in individuals with a history of severe, life-threatening delayed hypersensitivity reactions, which may manifest as severe cutaneous adverse reactions like Stevens-Johnson Syndrome, as well as hepatitis, nephritis, serum sickness, and hemolytic anemia in response to penicillin.
Furthermore, the authors point out that more than 90% of individuals with a documented penicillin allergy do not have true allergies as confirmed by skin testing. To address this, they recommend increasing referrals for penicillin allergy testing as part of routine obstetric care and preoperative assessments to improve antibiotic prophylaxis practices. The study authors also stress the need for greater education among healthcare providers regarding penicillin allergy assessments and the potential cross-reactivity between penicillins and cephalosporins, aiming to optimize antibiotic prophylaxis in obstetrics and gynecology.
This prompted the authors to conclude that cefazolin is suitable for antimicrobial prophylaxis in most patients with a penicillin allergy, even those who have experienced an anaphylactic reaction to penicillin. The only exceptions are individuals with a history of severe, life-threatening delayed hypersensitivity reactions, including Stevens-Johnson Syndrome.
"Increased referral for penicillin allergy testing should be incorporated into our routine obstetric care and preoperative assessment," they wrote.
Reference:
Dutra, K. J., Lazenby, G. B., Goje, O., & Soper, D. E. (2024). Cefazolin as the mainstay for antibiotic prophylaxis in patients with a penicillin allergy in obstetrics and gynecology. American Journal of Obstetrics and Gynecology, 231(4), 430-436. https://doi.org/10.1016/j.ajog.2024.03.019
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at  editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751